Inventor
SCHEUERER STEFAN
DE25 patents
⚠️ This page may combine multiple inventors who share the name “SCHEUERER STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EBEL HEINER
8 patentsUS8962656B2Feb 24, 2015
CCR2 antagonists
EBEL HEINER9 citations83
US8841313B2Sep 23, 2014
CCR2 antagonists and uses thereof
EBEL HEINER9 citations83
US8765949B2Jul 1, 2014
CCR2 receptor antagonists and uses thereof
EBEL HEINER9 citations83
US8835440B2Sep 16, 2014
Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
EBEL HEINER9 citations82
US9108958B2Aug 18, 2015
Selective CCR2 antagonists
EBEL HEINER4 citations72
US8877745B2Nov 4, 2014
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EBEL HEINER2 citations51
US9018212B2Apr 28, 2015
Pyridazine carboxamides as CCR2 receptor antagonists
EBEL HEINER0 citations41
US8946218B2Feb 3, 2015
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EBEL HEINER0 citations41
BOEHRINGER INGELHEIM INT
8 patentsUS7517995B2Apr 14, 2009
Thiazolyl-dihydro-cyclopentapyrazole
BOEHRINGER INGELHEIM INT10 citations83
US9884854B2Feb 6, 2018
N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT6 citations71
US7691888B2Apr 6, 2010
Thiazolyl-dihydro-indazole
BOEHRINGER INGELHEIM INT7 citations71
US11324724B2May 10, 2022
N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations61
US7691868B2Apr 6, 2010
Thiazolyl-dihydro-quinazoline
BOEHRINGER INGELHEIM INT3 citations61
US11236072B2Feb 1, 2022
N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations59
US10710984B2Jul 14, 2020
N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations50
US8354418B2Jan 15, 2013
Thiazolyl-dihydro-quinazolines
BOEHRINGER INGELHEIM INT0 citations40
CENTREXION THERAPEUTICS CORP
5 patentsUS11046706B2Jun 29, 2021
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP3 citations83
US10196402B2Feb 5, 2019
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP7 citations83
US9670222B2Jun 6, 2017
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP9 citations83
US11731981B2Aug 22, 2023
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP1 citations72
US12209094B2Jan 28, 2025
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP0 citations62